Literature DB >> 29687454

Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.

Susan R Kahn1, David R Morrison, Gisèle Diendéré, Alexandre Piché, Kristian B Filion, Adi J Klil-Drori, James D Douketis, Jessica Emed, André Roussin, Vicky Tagalakis, Martin Morris, William Geerts.   

Abstract

BACKGROUND: Venous thromboembolism (VTE) is a leading cause of morbidity and mortality in hospitalized patients. While numerous randomized controlled trials (RCTs) have shown that the appropriate use of thromboprophylaxis in hospitalized patients at risk for VTE is safe, effective, and cost-effective, thromboprophylaxis remains underused or inappropriately used. Our previous review suggested that system-wide interventions, such as education, alerts, and multifaceted interventions were more effective at improving the prescribing of thromboprophylaxis than relying on individual providers' behaviors. However, 47 of the 55 included studies in our previous review were observational in design. Thus, an update to our systematic review, focused on the higher level of evidence of RCTs only, was warranted.
OBJECTIVES: To assess the effects of system-wide interventions designed to increase the implementation of thromboprophylaxis and decrease the incidence of VTE in hospitalized adult medical and surgical patients at risk for VTE, focusing on RCTs only. SEARCH
METHODS: Our research librarian conducted a systematic literature search of MEDLINE Ovid, and subsequently translated it to CENTRAL, PubMed, Embase Ovid, BIOSIS Previews Ovid, CINAHL, Web of Science, the Database of Abstracts of Reviews of Effects (DARE; in the Cochrane Library), NHS Economic Evaluation Database (EED; in the Cochrane Library), LILACS, and clinicaltrials.gov from inception to 7 January 2017. We also screened reference lists of relevant review articles. We identified 12,920 potentially relevant records. SELECTION CRITERIA: We included all types of RCTs, with random or quasi-random methods of allocation of interventions, which either randomized individuals (e.g. parallel group, cross-over, or factorial design RCTs), or groups of individuals (cluster RCTs (CRTs)), which aimed to increase the use of prophylaxis or appropriate prophylaxis, or decrease the occurrence of VTE in hospitalized adult patients. We excluded observational studies, studies in which the intervention was simply distribution of published guidelines, and studies whose interventions were not clearly described. Studies could be in any language. DATA COLLECTION AND ANALYSIS: We collected data on the following outcomes: the number of participants who received prophylaxis or appropriate prophylaxis (as defined by study authors), the occurrence of any VTE (symptomatic or asymptomatic), mortality, and safety outcomes, such as bleeding. We categorized the interventions into alerts (computer or human alerts), multifaceted interventions (combination of interventions that could include an alert component), educational interventions (e.g. grand rounds, courses), and preprinted orders (written predefined orders completed by the physician on paper or electronically). We meta-analyzed data across RCTs using a random-effects model. For CRTs, we pooled effect estimates (risk difference (RD) and risk ratio (RR), with 95% confidence interval (CI), adjusted for clustering, when possible. We pooled results if three or more trials were available for a particular intervention. We assessed the certainty of the evidence according to the GRADE approach. MAIN
RESULTS: From the 12,920 records identified by our search, we included 13 RCTs (N = 35,997 participants) in our qualitative analysis and 11 RCTs (N = 33,207 participants) in our meta-analyses. PRIMARY OUTCOME: Alerts were associated with an increase in the proportion of participants who received prophylaxis (RD 21%, 95% CI 15% to 27%; three studies; 5057 participants; I² = 75%; low-certainty evidence). The substantial statistical heterogeneity may be in part explained by patient types, type of hospital, and type of alert. Subgroup analyses were not feasible due to the small number of studies included in the meta-analysis.Multifaceted interventions were associated with a small increase in the proportion of participants who received prophylaxis (cluster-adjusted RD 4%, 95% CI 2% to 6%; five studies; 9198 participants; I² = 0%; moderate-certainty evidence). Multifaceted interventions with an alert component were found to be more effective than multifaceted interventions that did not include an alert, although there were not enough studies to conduct a pooled analysis. SECONDARY OUTCOMES: Alerts were associated with an increase in the proportion of participants who received appropriate prophylaxis (RD 16%, 95% CI 12% to 20%; three studies; 1820 participants; I² = 0; moderate-certainty evidence). Alerts were also associated with a reduction in the rate of symptomatic VTE at three months (RR 64%, 95% CI 47% to 86%; three studies; 5353 participants; I² = 15%; low-certainty evidence). Computer alerts were associated with a reduction in the rate of symptomatic VTE, although there were not enough studies to pool computer alerts and human alerts results separately. AUTHORS'
CONCLUSIONS: We reviewed RCTs that implemented a variety of system-wide strategies aimed at improving thromboprophylaxis in hospitalized patients. We found increased prescription of prophylaxis associated with alerts and multifaceted interventions, and increased prescription of appropriate prophylaxis associated with alerts. While multifaceted interventions were found to be less effective than alerts, a multifaceted intervention with an alert was more effective than one without an alert. Alerts, particularly computer alerts, were associated with a reduction in symptomatic VTE at three months, although there were not enough studies to pool computer alerts and human alerts results separately.Our analysis was underpowered to assess the effect on mortality and safety outcomes, such as bleeding.The incomplete reporting of relevant study design features did not allow complete assessment of the certainty of the evidence. However, the certainty of the evidence for improvement in outcomes was judged to be better than for our previous review (low- to moderate-certainty evidence, compared to very low-certainty evidence for most outcomes). The results of our updated review will help physicians, hospital administrators, and policy makers make practical decisions about adopting specific system-wide measures to improve prescription of thromboprophylaxis, and ultimately prevent VTE in hospitalized patients.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29687454      PMCID: PMC6747554          DOI: 10.1002/14651858.CD008201.pub3

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  96 in total

Review 1.  Thromboprophylaxis in surgical and medical patients.

Authors:  Silvia Bozzato; Luca Galli; Walter Ageno
Journal:  Semin Respir Crit Care Med       Date:  2012-05-30       Impact factor: 3.119

2.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Hospitalizations, Therapies, and Outcomes of Pulmonary Embolism in Medicare Beneficiaries: Trends Are Similar to Europe.

Authors:  Behnood Bikdeli; Yun Wang; Karl E Minges; Nihar R Desai
Journal:  J Am Coll Cardiol       Date:  2016-05-31       Impact factor: 24.094

4.  Trends in the incidence of pulmonary embolism and deep venous thrombosis in hospitalized patients.

Authors:  Paul D Stein; Afzal Beemath; Ronald E Olson
Journal:  Am J Cardiol       Date:  2005-06-15       Impact factor: 2.778

Review 5.  Thromboprophylaxis in nonsurgical patients.

Authors:  Michael B Streiff; Brandyn D Lau
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2012

6.  Trends in case fatality rate in pulmonary embolism according to stability and treatment.

Authors:  Paul D Stein; Fadi Matta; Ahmed Alrifai; Akhil Rahman
Journal:  Thromb Res       Date:  2012-08-19       Impact factor: 3.944

7.  National Trends in Pulmonary Embolism Hospitalization Rates and Outcomes for Adults Aged ≥65 Years in the United States (1999 to 2010).

Authors:  Karl E Minges; Behnood Bikdeli; Yun Wang; Nancy Kim; Jeptha P Curtis; Mayur M Desai; Harlan M Krumholz
Journal:  Am J Cardiol       Date:  2015-08-14       Impact factor: 2.778

8.  Risk of venous thromboembolic disease and adequacy of prophylaxis in hospitalized patients in Argentina: a multicentric cross-sectional study.

Authors:  Fernando Vazquez; Ricardo Watman; Aldo Tabares; Carina Gumpel; Enrique Baldessari; Alicia B Vilaseca; Federico J Capparelli; Esteban Lifschitz
Journal:  Thromb J       Date:  2014-07-07

Review 9.  Practices to prevent venous thromboembolism: a brief review.

Authors:  Brandyn D Lau; Elliott R Haut
Journal:  BMJ Qual Saf       Date:  2013-05-24       Impact factor: 7.035

10.  Venous thromboembolism prophylaxis in patients undergoing abdominal and pelvic cancer surgery: adherence and compliance to ACCP guidelines in DIONYS registry.

Authors:  Melkart Basile; Maroon Tohmeh; Negib Geahchan
Journal:  Springerplus       Date:  2016-09-13
View more
  18 in total

1.  Use of Venous Thromboembolism Prophylaxis in Hospitalized Patients: Knowledge and Practice Among Physicians in Nepal.

Authors:  Amit Bhandari; Amit Khanal; Pratikshya Thapa; Ashish Thapa; Kushal Bhattarai; Bibhusan Basnet
Journal:  J Community Hosp Intern Med Perspect       Date:  2022-09-09

2.  A multicentre controlled pre-post trial of an implementation science intervention to improve venous thromboembolism prophylaxis in critically ill patients.

Authors:  Henry T Stelfox; Rebecca Brundin-Mather; Andrea Soo; Jeanna Parsons Leigh; Daniel J Niven; Kirsten M Fiest; Christopher James Doig; Danny J Zuege; Barry Kushner; Fiona Clement; Sharon E Straus; Deborah J Cook; Sean M Bagshaw; Khara M Sauro
Journal:  Intensive Care Med       Date:  2019-02-01       Impact factor: 17.440

3.  Effect on thromboprophylaxis among hospitalized patients using a system-wide multifaceted quality improvement intervention: Rationale and design for a multicenter cluster randomized clinical trial in China.

Authors:  Fen Dong; Kaiyuan Zhen; Zhu Zhang; Chaozeng Si; Jiefeng Xia; Tieshan Zhang; Lei Xia; Wei Wang; Cunbo Jia; Guangliang Shan; Zhenguo Zhai; Chen Wang
Journal:  Am Heart J       Date:  2020-05-07       Impact factor: 4.749

4.  Effectiveness of interventions for the implementation of thromboprophylaxis in hospitalised patients at risk of venous thromboembolism: an updated abridged Cochrane systematic review and meta-analysis of randomised controlled trials.

Authors:  Susan R Kahn; Gisele Diendéré; David R Morrison; Alexandre Piché; Kristian B Filion; Adi J Klil-Drori; James Douketis; Jessica Emed; André Roussin; Vicky Tagalakis; Martin Morris; William Geerts
Journal:  BMJ Open       Date:  2019-05-24       Impact factor: 2.692

5.  NSQIP Impacts Patient Experience.

Authors:  Maria Castaldi; Geena George; Pamela Turner; John McNelis
Journal:  J Patient Exp       Date:  2018-12-09

6.  Thromboprophylactic Efficacy and Safety of Anticoagulants After Arthroscopic Knee Surgery: A Systematic Review and Meta-Analysis.

Authors:  Yang Yu; Shitao Lu; Jinpeng Sun; Wei Zhou; Hongjian Liu
Journal:  Clin Appl Thromb Hemost       Date:  2019 Jan-Dec       Impact factor: 2.389

7.  Quality appraisal of clinical guidelines for venous thromboembolism prophylaxis in patients undergoing hip and knee arthroplasty: a systematic review.

Authors:  Yu Wang; Li-Yun Zhu; Hai-Bo Deng; Xu Yang; Lei Wang; Yuan Xu; Xiao-Jie Wang; Dong Pang; Jian-Hua Sun; Jing Cao; Ge Liu; Ying Liu; Yu-Fen Ma; Xin-Juan Wu
Journal:  BMJ Open       Date:  2020-12-10       Impact factor: 2.692

8.  Improving VTE risk assessment and prophylaxis prescribing rate in medical patients: integrating risk assessment tool into the workflow.

Authors:  Hannah Preston; Iain Swan; Lauren Davies; Simon Dummer; Veiraiah Aravindan; Yuan Ye Beh; Ann Lockman
Journal:  BMJ Open Qual       Date:  2020-06

9.  Outside any therapeutic trial prescription of hydroxychloroquine for hospitalized patients with covid-19 during the first wave of the pandemic: A national inquiry of prescription patterns among French hospitalists.

Authors:  Antoine Bosquet; Comlan Affo; Ludovic Plaisance; Géraldine Poenou; Emmanuel Mortier; Isabelle Mahé
Journal:  PLoS One       Date:  2022-01-21       Impact factor: 3.240

10.  Post-discharge venous thromboembolism after pancreatectomy for malignancy: Predicting risk based on preoperative, intraoperative, and postoperative factors.

Authors:  Cary Jo R Schlick; Ryan P Merkow; Anthony D Yang; David J Bentrem
Journal:  J Surg Oncol       Date:  2020-06-12       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.